Publizoom

ROCHE Farmacêutica Química, LDA

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won
30
Amount won alone
€20,309,850 excl. VAT
Period
6 July 2026 – 20 October 2026

Its main clients

Where and what

Supplies · 30

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned endContractCurrent holderAmount
5 December 2026
re-tender around October 2026		 2023/0491 - Trastuzumab [600 mg/ 5 ml sol inj sc frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €534,233
10 December 2026
re-tender around October 2026		 2025/1746 - Emicizumab [150 mg/ml 0,7 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €434,266
10 December 2026
re-tender around October 2026		 2025/1746 - Emicizumab [150 mg/ml 1 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €383,325
24 December 2026
re-tender around October 2026		 2023/0491 - Trastuzumab [600 mg/ 5 ml sol inj sc frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €122,812
30 December 2026
re-tender around October 2026		 2023/0491 - Atezolizumab [1200 mg/ 20 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €136,740
30 December 2026
re-tender around October 2026		 2023/0491 - Trastuzumab [600 mg/ 5 ml sol inj sc frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €143,012
30 December 2026
re-tender around October 2026		 2023/0491 - Trastuzumab emtansina [100 mg pó conc sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €103,971
1 January 2027
re-tender around October 2026		 2023/0491 - Trastuzumab emtansina [160 mg pó conc sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €111,307
5 January 2027
re-tender around October 2026		 2025/1746 - Emicizumab [150 mg/ml 0,4 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €1,778,787
5 January 2027
re-tender around October 2026		 2025/1746 - Emicizumab [30 mg/ml 1 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €268,329
5 January 2027
re-tender around October 2026		 2023/0491 - Trastuzumab emtansina [160 mg pó conc sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €298,301
5 January 2027
re-tender around October 2026		 2023/0491 - Trastuzumab emtansina [100 mg pó conc sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €499,487
5 January 2027
re-tender around October 2026		 2023/0491 - Alectinib [150 mg cáp/ comp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €579,072
5 January 2027
re-tender around October 2026		 2023/0491 - Pertuzumab + trastuzumab [60 + 60 mg/ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €1,364,407
5 January 2027
re-tender around October 2026		 2023/0491 - Polatuzumab vedotina [30 mg pó conc sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €234,842
5 January 2027
re-tender around October 2026		 2026/0002 - Risdiplam [60 mg pó sol oral frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €2,035,008
5 January 2027
re-tender around October 2026		 2025/1746 - Emicizumab [150 mg/ml 0,7 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €1,856,485
5 January 2027
re-tender around October 2026		 2023/0491 - Ocrelizumab [300 mg/ 10 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €2,320,673
5 January 2027
re-tender around October 2026		 2023/0491 - Trastuzumab [600 mg/ 5 ml sol inj sc frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €534,233
5 January 2027
re-tender around October 2026		 2023/0491 - Atezolizumab [1200 mg/ 20 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €697,042
5 January 2027
re-tender around October 2026		 2023/0491 - Rituximab [120 mg/ ml 11,7 ml frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €302,410
5 January 2027
re-tender around October 2026		 2023/0491 - Obinutuzumab [25 mg/ml 40 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €284,461
5 January 2027
re-tender around October 2026		 2025/1746 - Emicizumab [150 mg/ml 1 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €1,249,640
10 January 2027
re-tender around October 2026		 2025/1746 - Emicizumab [30 mg/ml 1 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €84,332
19 January 2027
re-tender around October 2026		 2023/0491 - Polatuzumab vedotina [30 mg pó conc sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €722,592
24 January 2027
re-tender around October 2026		 2023/0491 - Trastuzumab emtansina [100 mg pó conc sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €125,220
16 February 2027
re-tender around October 2026		 2023/0491 - Atezolizumab [1200 mg/ 20 ml sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement		 ROCHE Farmacêutica Química, LDA
1 bid received		 €166,757

Contracts won

DateContractBuyerAmount
20/10/2026 2025/1746 - Emicizumab [150 mg/ml 1 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €1,249,640
20/10/2026 2025/1746 - Emicizumab [150 mg/ml 1 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €383,325
13/10/2026 2023/0491 - Obinutuzumab [25 mg/ml 40 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €284,461
08/10/2026 C/ base no cpa 2025_1303 - ocrelizumab 920 mg/23 ml sol inj fr 23 ml sc Unidade Local de Saúde de Coimbra, EPE €1,615,945
06/10/2026 2023/0491 - Rituximab [120 mg/ ml 11,7 ml frs] Unidade Local de Saúde Santa Maria, E.P.E. €302,410
29/09/2026 2025/1746 - Emicizumab [30 mg/ml 1 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €268,329
29/09/2026 2023/0491 - Trastuzumab emtansina [160 mg pó conc sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €111,307
29/09/2026 2025/1746 - Emicizumab [30 mg/ml 1 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €84,332
29/09/2026 2023/0491 - Trastuzumab emtansina [160 mg pó conc sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €298,301
22/09/2026 2023/0491 - Trastuzumab emtansina [100 mg pó conc sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €499,487
22/09/2026 2023/0491 - Trastuzumab emtansina [100 mg pó conc sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €125,220
22/09/2026 2023/0491 - Trastuzumab [600 mg/ 5 ml sol inj sc frs] Unidade Local de Saúde Santa Maria, E.P.E. €534,233
22/09/2026 2023/0491 - Trastuzumab emtansina [100 mg pó conc sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €103,971
15/09/2026 2023/0491 - Alectinib [150 mg cáp/ comp] Unidade Local de Saúde Santa Maria, E.P.E. €579,072
14/09/2026 Com base no cpa 2025_1303 - Glofitamab - justificação clinica Unidade Local de Saúde de Coimbra, EPE €1,064,280
11/08/2026 2023/0491 - Pertuzumab + trastuzumab [60 + 60 mg/ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €1,364,407
11/08/2026 2023/0491 - Polatuzumab vedotina [30 mg pó conc sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €234,842
11/08/2026 2023/0491 - Polatuzumab vedotina [30 mg pó conc sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €722,592
04/08/2026 2026/0002 - Risdiplam [60 mg pó sol oral frs] Unidade Local de Saúde Santa Maria, E.P.E. €2,035,008
04/08/2026 2025/1746 - Emicizumab [150 mg/ml 0,4 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €1,778,787
28/07/2026 2025/1746 - Emicizumab [150 mg/ml 0,7 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €1,856,485
28/07/2026 2025/1746 - Emicizumab [150 mg/ml 0,7 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €434,266
28/07/2026 2023/0491 - Ocrelizumab [300 mg/ 10 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €2,320,673
21/07/2026 2023/0491 - Trastuzumab [600 mg/ 5 ml sol inj sc frs] Unidade Local de Saúde Santa Maria, E.P.E. €534,233
21/07/2026 2023/0491 - Trastuzumab [600 mg/ 5 ml sol inj sc frs] Unidade Local de Saúde Santa Maria, E.P.E. €122,812
21/07/2026 2023/0491 - Trastuzumab [600 mg/ 5 ml sol inj sc frs] Unidade Local de Saúde Santa Maria, E.P.E. €143,012
07/07/2026 2023/0491 - Atezolizumab [1200 mg/ 20 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €166,757
07/07/2026 2023/0491 - Atezolizumab [1200 mg/ 20 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €697,042
07/07/2026 2023/0491 - Atezolizumab [1200 mg/ 20 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €136,740
06/07/2026 1363426 Aquisição de RISDIPLAM 5 MG COMP 2026 Unidade Local de Saúde Gaia/Espinho, E.P.E. €257,880

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.